Longeveron Inc [LGVN] stock is trading at $1.55, up 5.44%. One of the good ways to gauge the recent performance is if the stock’s short-term value is rising or falling. The LGVN shares have gain 16.54% over the last week, with a monthly amount glided 1.97%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Longeveron Inc [NASDAQ: LGVN] stock has seen the most recent analyst activity on December 06, 2024, when ROTH MKM initiated its Buy rating and assigned the stock a price target of $10.
Longeveron Inc [LGVN] stock has fluctuated between $0.77 and $6.40 over the past year. Currently, Wall Street analysts expect the stock to reach $10 within the next 12 months. Longeveron Inc [NASDAQ: LGVN] shares were valued at $1.55 at the most recent close of the market. An investor can expect a potential return of 545.16% based on the average LGVN price forecast.
Analyzing the LGVN fundamentals
Longeveron Inc [NASDAQ:LGVN] reported sales of 2.39M for the trailing twelve months, which represents a growth of 857.14%. Gross Profit Margin for this corporation currently stands at 0.68% with Operating Profit Margin at -6.91%, Pretax Profit Margin comes in at -6.74%, and Net Profit Margin reading is -6.68%. To continue investigating profitability, this company’s Return on Assets is posted at -0.62, Equity is -0.98 and Total Capital is -0.72. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.07.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 1.4267 points at the first support level, and at 1.3033 for the second support level. However, for the 1st resistance point, the stock is sitting at 1.6467, and for the 2nd resistance point, it is at 1.7433.
Ratios To Look Out For
For context, Longeveron Inc’s Current Ratio is 7.60. Also, the Quick Ratio is 7.60, while the Cash Ratio stands at 7.45. Considering the valuation of this stock, the price to sales ratio is 9.70, the price to book ratio is 1.05.
Transactions by insiders
Recent insider trading involved Baluch Khoso, Director, that happened on Dec 02 ’24 when 1250.0 shares were sold. Director, Baluch Khoso completed a deal on Nov 27 ’24 to buy 1250.0 shares. Meanwhile, Chief Scientific Officer Hare Joshua bought 0.11 million shares on Apr 10 ’24.
